Vincent Irrling’s Post

View profile for Vincent Irrling, graphic

Accelerating HealthTech Innovation at KAPSLY & MEDKAP

💡 When to Build, Buy, Partner, or Invest: Navigating MedTech Innovation In today’s #MedTech world, #innovation isn’t just about staying in the game—it’s about leading it. In my latest blog, I dive into the critical decision-making framework that helps companies decide whether to #build, #buy, #partner, or #invest in innovation. Here’s a quick look at the strategies I unpack: 🔬 Internal R&D – Perfect for innovations aligned with your core strengths and where market solutions don’t exist. 🚀 Corporate Venture Building – Ideal for disruptive projects that thrive outside traditional structures. 🌐 Corporate Venture Capital (CVC) – Stay informed and engaged with startups while pursuing financial returns. 🤝 Venture Partnering – Collaborate on joint projects that drive competitive advantage. ⚡ Venture Clienting – Fast-track innovation with startup solutions through low-risk pilot projects. 📈 M&A – The ultimate step, best approached after strong collaboration and compatibility testing. Flexibility and adaptation are essential. Start with collaboration, explore investments, and pivot as needed. It’s not just about the tools you use; it’s about how you align them with your goals. At KAPSLY and MEDKAP, I’m committed to helping MedTech corporates stay ahead with tailored strategies that foster innovation. Whether through Venture Clienting, Venture Building, or strategic investments, I can guide you in making the right decisions to thrive in this dynamic industry. 💬 Ready to drive innovation together? Join our upcoming webinar on Corporate innovation with Frank Desiere: https://lnkd.in/gmQSna53 read more click the link in the comment 👇

  • diagram

To view or add a comment, sign in

Explore topics